肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）

2021-10-28 韩国妇科肿瘤学会 J Gynecol Oncol

人乳头瘤病毒疫苗

2021年10月，韩国妇科肿瘤学会(KSGO)更新了人乳头瘤病毒疫苗指南。指南主要针对人乳头瘤病毒疫苗的3个关键问题提出指导建议。

中文标题：

2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）

英文标题：

Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines

发布机构：

韩国妇科肿瘤学会

发布日期：

2021-10-28

简要介绍：

2021年10月，韩国妇科肿瘤学会(KSGO)更新了人乳头瘤病毒疫苗指南。指南主要针对人乳头瘤病毒疫苗的3个关键问题提出指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6c7b11c0022a2908, title=2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）, enTitle=Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines, guiderFrom=J Gynecol Oncol, authorId=0, author=, summary=2021年10月，韩国妇科肿瘤学会(KSGO)更新了人乳头瘤病毒疫苗指南。指南主要针对人乳头瘤病毒疫苗的3个关键问题提出指导建议。, cover=https://img.medsci.cn/20211028/1635431441617_1739456.jpg, journalId=0, articlesId=null, associationId=1290, associationName=韩国妇科肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Oct 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，韩国妇科肿瘤学会(KSGO)更新了人乳头瘤病毒疫苗指南。指南主要针对人乳头瘤病毒疫苗的3个关键问题提出指导建议。</span></p>, tagList=[TagDto(tagId=70266, tagName=人乳头瘤病毒疫苗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=70266, guiderKeyword=人乳头瘤病毒疫苗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2574, appHits=116, showAppHits=0, pcHits=605, showPcHits=2458, likes=0, shares=13, comments=5, approvalStatus=1, publishedTime=Fri Oct 29 13:48:22 CST 2021, publishedTimeString=2021-10-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Oct 29 11:53:00 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 21:03:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）.pdf)])
2021 KSGO临床指南：人乳头瘤病毒疫苗（更新版）.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069257, encodeId=c11e106925e0e, content=居然还有下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef7e5705463, createdName=ms8000002139912783, createdTime=Thu Nov 11 13:15:18 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066237, encodeId=0f95106623e51, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:45 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065226, encodeId=6c6f1065226a4, content=居然还要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sat Oct 30 09:48:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064989, encodeId=a0c110649897e, content=想学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e725635275, createdName=ms6000001949499379, createdTime=Fri Oct 29 15:05:56 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-11-11 ms8000002139912783

    居然还有下载

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069257, encodeId=c11e106925e0e, content=居然还有下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef7e5705463, createdName=ms8000002139912783, createdTime=Thu Nov 11 13:15:18 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066237, encodeId=0f95106623e51, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:45 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065226, encodeId=6c6f1065226a4, content=居然还要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sat Oct 30 09:48:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064989, encodeId=a0c110649897e, content=想学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e725635275, createdName=ms6000001949499379, createdTime=Fri Oct 29 15:05:56 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-11-02 ms6000001387765207

    very good idea

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069257, encodeId=c11e106925e0e, content=居然还有下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef7e5705463, createdName=ms8000002139912783, createdTime=Thu Nov 11 13:15:18 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066237, encodeId=0f95106623e51, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:45 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065226, encodeId=6c6f1065226a4, content=居然还要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sat Oct 30 09:48:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064989, encodeId=a0c110649897e, content=想学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e725635275, createdName=ms6000001949499379, createdTime=Fri Oct 29 15:05:56 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-10-30 12346c4dm64暂无昵称

    居然还要下载

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069257, encodeId=c11e106925e0e, content=居然还有下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef7e5705463, createdName=ms8000002139912783, createdTime=Thu Nov 11 13:15:18 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066237, encodeId=0f95106623e51, content=very good idea, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Tue Nov 02 14:54:45 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065226, encodeId=6c6f1065226a4, content=居然还要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2b82397018, createdName=12346c4dm64暂无昵称, createdTime=Sat Oct 30 09:48:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064989, encodeId=a0c110649897e, content=想学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e725635275, createdName=ms6000001949499379, createdTime=Fri Oct 29 15:05:56 CST 2021, time=2021-10-29, status=1, ipAttribution=)]
    2021-10-29 ms6000001949499379

    想学

    0

相关指南

青春前期女性接种人乳头瘤病毒疫苗专家共识

中山大学附属第三医院 · 2021-09-20

2020 ACOG委员会意见：人乳头瘤病毒疫苗接种（No.809）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2020-08-13

2017年WHO HPV疫苗立场文件的解读

暂未更新 · 2018-05-15

WHO关于人乳头瘤病毒疫苗的意见书

暂未更新 · 2017-12-30

拓展阅读

WHO关于人乳头瘤病毒疫苗的意见书

暂未更新 · 2017-12-30

2017年WHO HPV疫苗立场文件的解读

暂未更新 · 2018-05-15

2020 ACOG委员会意见：人乳头瘤病毒疫苗接种（No.809）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2020-08-13

青春前期女性接种人乳头瘤病毒疫苗专家共识

中山大学附属第三医院 · 2021-09-20

关于公开征求《人乳头瘤病毒疫苗临床试验技术指导原则（征求意见稿）》意见的通知

国家药品监督管理局药品审评中心（CDE） · 2022-10-26

人乳头瘤病毒疫苗临床应用中国专家共识（2021年版）解读

华中科技大学同济医学院附属同济医院妇产科 · 2022-12-15